Finance

Lists
1177:HKG
Sino Biopharmaceutical Ltd
5,25 HKD
-0,38%
(-0,020) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
5,40 HKD
High
5,50 HKD
Low
5,14 HKD
Mkt. cap
98,09 მლრდ.
Avg. vol.
69,33 მლნ.
Volume
83,88 მლნ.
Dividend
2,29%
Quarterly dividend
0,03 HKD
Ex-dividend date
29 აგვ. 2025
P/E ratio
33,86
52-wk high
7,79 HKD
52-wk low
4,19 HKD
EPS
0,16 HKD
Shares outstanding
12,64 მლრდ.
No. of employees
23 ათ.
Open
5,40 HKD
High
5,50 HKD
Low
5,14 HKD
Mkt. cap
98,09 მლრდ.
Avg. vol.
69,33 მლნ.
Volume
83,88 მლნ.
Dividend
2,29%
Quarterly dividend
0,03 HKD
Ex-dividend date
29 აგვ. 2025
P/E ratio
33,86
52-wk high
7,79 HKD
52-wk low
4,19 HKD
EPS
0,16 HKD
Shares outstanding
12,64 მლრდ.
No. of employees
23 ათ.
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
8 წუთის წინ
S&P 500 Earnings Yield Jumps Over 5%; Sold The EMXC
https://tech-insider.org/
https://tech-insider.org/
·
16 წუთის წინ
Nasdaq Futures Rebound 0.7% as Earnings Week Looms
marketscreener.com
marketscreener.com
·
26 წუთის წინ
S&P 500 index slipped after the Stockholm exchange closed on Friday
Stocktwits
Stocktwits
·
37 წუთის წინ
No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious
Profile
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
CEOლი აი
Employees22,8 ათ.
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitesbpgroup.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
7,13 მლრდ.
7,13 მლრდ.
9,72 მლრდ.
9,72 მლრდ.
Cost of goods sold
1,31 მლრდ.
1,31 მლრდ.
1,65 მლრდ.
1,65 მლრდ.
Cost of revenue
1,31 მლრდ.
1,31 მლრდ.
1,65 მლრდ.
1,65 მლრდ.
Research and development expenses
2,93 მლრდ.
2,93 მლრდ.
1,54 მლრდ.
1,54 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,80 მლრდ.
2,80 მლრდ.
3,11 მლრდ.
3,11 მლრდ.
Operating expense
4,38 მლრდ.
4,38 მლრდ.
4,77 მლრდ.
4,77 მლრდ.
Total operating expenses
5,69 მლრდ.
5,69 მლრდ.
6,42 მლრდ.
6,42 მლრდ.
Operating income
1,44 მლრდ.
1,44 მლრდ.
3,31 მლრდ.
3,31 მლრდ.
Other non operating income
97,99 მლნ.
97,99 მლნ.
76,64 მლნ.
76,64 მლნ.
EBT including unusual items
488,22 მლნ.
488,22 მლნ.
3,67 მლრდ.
3,67 მლრდ.
EBT excluding unusual items
1,55 მლრდ.
1,55 მლრდ.
3,56 მლრდ.
3,56 მლრდ.
Income tax expense
323,77 მლნ.
323,77 მლნ.
597,96 მლნ.
597,96 მლნ.
Effective tax rate
66,32%
66,32%
16,29%
16,29%
Other operating expenses
-1,35 მლრდ.
-1,35 მლრდ.
113,21 მლნ.
113,21 მლნ.
Net income
-522,62 მლნ.
-522,62 მლნ.
1,72 მლრდ.
1,72 მლრდ.
Net profit margin
-7,33%
-7,33%
17,66%
17,66%
Earnings per share
-
-
-
-
Interest and investment income
196,36 მლნ.
196,36 მლნ.
250,06 მლნ.
250,06 მლნ.
Interest expense
-77,56 მლნ.
-77,56 მლნ.
-84,75 მლნ.
-84,75 მლნ.
Net interest expenses
118,80 მლნ.
118,80 მლნ.
165,31 მლნ.
165,31 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 მლრდ.
1,66 მლრდ.
3,57 მლრდ.
3,57 მლრდ.
Gain or loss from assets sale
-5,58 მლნ.
-5,58 მლნ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები